EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Nomogram for Predicting Tenofovir-Associated Osteoporosis in Chronic Hepatitis B

Elif Can Semet, Cihan Semet iD

Journal of Clinical Medicine · 09.06.2026 · 15 (12) · 4442

DOI: 10.3390/jcm15124442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.06.2026. Verfasst von Elif Can Semet und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Bandırma Training and Research Hospital, Balıkesir 10200, Türkiye. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Long-term tenofovir disoproxil fumarate (TDF) therapy is associated with progressive bone mineral density loss in patients with chronic hepatitis B (CHB), yet existing fracture risk algorithms, such as FRAX, were not designed for this population. We aimed to develop and internally validate a clinical nomogram for identifying TDF-associated osteoporosis using penalized regression on demographic, virological, and biochemical predictors.

Methods

In this single-center retrospective cohort study, 237 adult CHB patients receiving TDF for at least 12 months underwent dual-energy X-ray absorptiometry (DXA). Osteoporosis was defined as a T-score of −2.5 or lower at the lumbar spine or femoral neck. Thirteen candidate predictors were evaluated using LASSO regression with 10-fold cross-validation; selected variables were entered into an unpenalized multivariable logistic regression model; internal validation employed bootstrap resampling with 200 replications to derive optimism-corrected estimates of discrimination and calibration. The clinical utility was assessed using decision curve analysis (DCA).

Results

Osteoporosis prevalence was 15.2% (n = 36). LASSO selected three predictors: prior fragility fracture (OR 11.45, 95% CI 4.82–27.15), the Charlson Comorbidity Index (OR 1.45 per unit, 95% CI 1.15–1.85), and alkaline phosphatase. The model demonstrated strong discrimination (apparent C-index 0.860; optimism-corrected 0.845) with excellent calibration (slope 0.94, intercept 0.02; Brier score 0.095). At a 0.15 probability threshold, sensitivity was 86.0%, specificity 78.0%, and negative predictive value 97.0%. DCA confirmed superior net clinical benefit over default strategies across the 0.10–0.30 threshold range; a pre-specified sensitivity analysis excluding fracture history retained meaningful discrimination (corrected C-index 0.791).

Conclusions

This nomogram offers a clinically actionable, disease-specific tool for stratifying osteoporosis risk in TDF-treated CHB patients, particularly well suited for safely deferring DXA imaging in low-risk individuals. External validation in multicenter and ethnically diverse cohorts is required before widespread implementation.

Schlagwörter

Stichwörter der Autor:innen

DXA screeningLASSO regressionchronic hepatitis Bclinical prediction modeldecision curve analysisnomogramosteoporosistenofovir disoproxil fumarate

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, Bandırma Training and Research Hospital, Balıkesir 10200, Türkiye.
  • Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bandırma Onyedi Eylül University, Balıkesir 10250, Türkiye.

ORCID-Profile: Cihan Semet

Zitieren

APA

Semet, E. C., & Semet, C. (2026). A Nomogram for Predicting Tenofovir-Associated Osteoporosis in Chronic Hepatitis B. Journal of Clinical Medicine, 15(12), 4442. https://doi.org/10.3390/jcm15124442

Vancouver

Semet EC, Semet C. A Nomogram for Predicting Tenofovir-Associated Osteoporosis in Chronic Hepatitis B. Journal of Clinical Medicine. 2026;15(12):4442. doi:10.3390/jcm15124442

BibTeX
@article{Semet2026,
  author = {Semet, Elif Can and Semet, Cihan},
  title = {A Nomogram for Predicting Tenofovir-Associated Osteoporosis in Chronic Hepatitis B},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4442},
  doi = {10.3390/jcm15124442}
}
Kostenlos starten →